Citations

Clear

367 citation(s) found for "Du, Pan".

Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features
Wu, Jiang , Cai, Muyan , Li, Shiyong , Bei, Jin‐Xin , Wang, Fang , Ling, Yihong , Rodrı́guez-Bigas, Miguel A. , Dignam, James J. , Mao, Mao , Li, Jibin , Guo, Yun‐Miao , Wu, Xiaoyan , Kong, Lingheng , Tang, Jing‐Hua, Li, Chao‐Feng, Chen, Jie‐Rong, Ye, Ming‐Zhi, Guo, Fengming, Han, Peng , Wan, Desen, Li, Li , Xu, Rui‐Hua , Ding, Pei-Rong , Group, Written on behalf of AME Colorectal Cancer Cooperative, Xu, Rui‐Hua , Jiang, Wu , Xu, Rui-Hua , Hampel, Heather , Frayling, Ian M. , Sinicrope, Frank A. , Kerr, David , Rosell, Rafael , Kong, Ling‐Heng, Tang, Jing-Hua , Wu, Xiaodan , Ou, Qingjian , Ye, Ming-Zhi, Wang, Qiwei , Pan, Zhizhong , Group, Written on behalf of AME Colorectal Cancer Cooperative

Mayo Clinic

International Journal of Cancer | December 6, 2018 | Volume: 144 | Issue: 9 | Pages: 2161-2168

10.1002/ijc.32044 | PMID 30521064 Get It

The prevalence of Lynch syndrome (LS) varies significantly in different populations, suggesting that ethnic features might play an important role. We enrolled 3330 consecutive Chinese patients who had surgical resection for newly diagnosed colorectal cancer. Universal screening for LS was implemented, including immunohistochemistry for mismatch repair (MMR) proteins, BRAFV600E mutation test and germline sequencing. Among the 3250 eligible patients, MMR protein deficiency (dMMR) was detected in 330 (10.2%) patients. Ninety‐three patients (2.9%) were diagnosed with LS. Nine (9.7%) patients with LS fulfilled Amsterdam criteria II and 76 (81.7%) met the revised Bethesda guidelines. Only 15 (9.7%) patients with absence of MLH1 on IHC had BRAFV600E mutation. One third (33/99) of the MMR gene mutations have not been reported previously. The age of onset indicates risk of LS in patients with dMMR tumors. For patients older than 65 years, only 2 patients (5.7%) fulfilling revised Bethesda guidelines were diagnosed with LS. Selective sequencing of all cases with dMMR diagnosed at or below age 65 years and only of those dMMR cases older than 65 years who fulfill revised Bethesda guidelines results in 8.2% fewer cases requiring germline testing without missing any LS diagnoses. While the prevalence of LS in Chinese patients is similar to that of Western populations, the spectrum of constitutional mutations and frequency of BRAFV600E mutation is different. Patients older than 65 years who do not meet the revised Bethesda guidelines have a low risk of LS, suggesting germline sequencing might not be necessary in this population.
Dispersion analysis of PoTRA ranked mRNA mediated dysregulated pathways in Breast Invasive Cancer from a TCGA Pan-Cancer study
Linan, Margaret, Dinu, Valentin

Mayo Clinic

No container title available | October 30, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7287/peerj.preprints.27306v1 Get It

Background. Our publication of the new pathways of topological rank analysis (PoTRA) algorithm demonstrated a novel approach for using the Google Search PageRank algorithm to analyze gene expression networks to identify biological pathways significantly disrupted in hepatocellular carcinoma. In order to apply the PoTRA algorithm to analyze other cancer gene expression data sets, of various sizes and normal:tumor ratio composition, two important questions must be answered: 1. What is the optimal normal:tumor sample ratio?; and 2. What is the minimum number of samples that should be used for PoTRA analysis? To address these questions, the average standard deviation (SD) in PoTRA-ranked mRNA mediated dysregulated pathways was studied using randomly sampled data sets with various normal:tumor ratios and sizes drawn from the TCGA Breast Invasive Carcinoma (TCGA-BRCA) project. Methods. To identify the optimal normal:tumor sample ratios, the SD analysis used random combinations of 1:N unbalanced normal:tumor data sets: (1:1, 1:2, 1:3, 1:5, 1:7, 1:9). To identify the minimum sample size, random resampling of normal and tumor samples of various sizes are used: (3 vs 3), (5 vs 5), (10 vs 10), (25 vs 25), (50 vs 50), (75 vs 75), (100 vs 100), and (113 vs 113). Results. This analysis suggests that the 1:1 ratio achieves the lowest average rank variation and that the minimum sample size of 50 normal and 50 tumor samples reaches a steady state in the average rank variation. Conclusion. In conclusion, future applications of the PoTRA algorithm to analyze gene expression data sets such as TCGA should use balanced data sets as well as a minimum sample size of 50 for both normal and tumor to ensure the most robust performance.
Longitudinal changes in patient-reported symptoms and physical function during taxane-based chemotherapy in breast cancer patients.
Monfort, Scott M. , Pan, Xueliang , Patrick, Robyn , Singaravelu, Janani, Mrózek, Ewa, Ramaswamy, Bhuvaneswari , Reinbolt, Raquel E. , Naughton, Michelle J. , Loprinzi, Charles L. , Chaudhari, Ajit M.W. , Layman, Rachel M. , Wesolowski, Robert , Shapiro, Charles L. , Lustberg, Maryam B.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 10098-10098

10.1200/jco.2016.34.15_suppl.10098 Get It

Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
Chen, Xujiao , Gao, Shouhong , Ruan, Mengna, Chen, Sixiu , Xu, Jing , Xing, Xiaohong , Pan, Xiaohong , Mei, Changlin , Mao, Zhiguo , Pan, Xiaohong

Mayo Clinic

Bioscience Reports | June 19, 2018 | Volume: 38 | Issue: 5 | Pages: No page available

10.1042/bsr20171694 | PMID 29921575 Get It

Clearance of protein-bound uremic toxins (PBUTs) by dialysis is a challenge in the treatment of uremic patients. Shen-Shuai-Ning (SSN), a traditional Chinese medicine formulation, has been used commonly in China to retard kidney disease progression and decrease uremic toxins in chronic kidney disease (CKD) patients, but the effects of SSN on serum PBUTs in dialysis patients were not investigated. We conducted a randomized controlled trial in patients on peritoneal dialysis (PD) at dialysis center of Changzheng Hospital to evaluate the effects of SSN on serum PBUTs. Participants with SSN intervention took 5 g SSN granule three times daily for 12 weeks, while the baseline medications and dialysis prescriptions remained during the study in all patients. The serum concentrations of indoxyl sulphate (IS) and p-cresol sulphate (PCS) were determined by HPLC/MS/MS and biochemical parameters were assessed during the study. Sixty PD patients were enrolled and randomly allocated into SSN group and control group. Total IS level was significantly lower in SSN group than in control group at week 4, 8, and 12 (27.28 ± 18.19, 29.73 ± 19.10, and 29.41 ± 17.61 mg/l compared with 39.25 ± 20.23, 44.86 ± 23.91, and 45.34 ± 33.52 mg/l, respectively). However, there were no statistical difference of total PCS, free forms of IS and PCS concentrations between SSN group and control group during 12 weeks follow-up. Administration of SSN granule orally decreased serum total IS level effectively in uremic patients on PD with good tolerance. Benefits of PD patients’ outcomes from IS reduction by SSN awaits further large size and long duration clinical trials to verify.
Neurokinin 3 receptor antagonists for treatment of vasomotor symptoms: a new panacea or just a flash in the pan?
Stuenkel, Cynthia A. , Faubion, Stephanie S.

Mayo Clinic

Menopause | June 5, 2018 | Volume: 25 | Issue: 8 | Pages: 859-861

10.1097/gme.0000000000001144 | PMID 29870472 Get It

TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53 -Mutated Prostate Cancer
Blee, Alexandra M. , He, Yundong , Yang, Yinhui , Ye, Zhenqing , Yan, Yuqian , Pan, Yunqian , Dugdale, Joseph , Kuehn, E. Wolfgang , Jiménez, Rafael E. , Chen, Yu , Xu, Wanhai , Kuehn, Emily, Kohli, Manish , Jimenez, Rafael, Ma, Tao , Chen, Yu , Wang, Liguo , Huang, Haojie

Mayo Clinic

Clinical Cancer Research | May 29, 2018 | Volume: 24 | Issue: 18 | Pages: 4551-4565

10.1158/1078-0432.ccr-18-0653 | PMID 29844131 Get It

Abstract Purpose: Deletions or mutations in PTEN and TP53 tumor suppressor genes have been linked to lineage plasticity in therapy-resistant prostate cancer. Fusion-driven overexpression of the oncogenic transcription factor ERG is observed in approximately 50% of all prostate cancers, many of which also harbor PTEN and TP53 alterations. However, the role of ERG in lineage plasticity of PTEN/TP53–altered tumors is unclear. Understanding the collective effect of multiple mutations within one tumor is essential to combat plasticity-driven therapy resistance. Experimental Design: We generated a Pten-negative/Trp53-mutated/ERG-overexpressing mouse model of prostate cancer and integrated RNA-sequencing with ERG chromatin immunoprecipitation-sequencing (ChIP-seq) to identify pathways regulated by ERG in the context of Pten/Trp53 alteration. We investigated ERG-dependent sensitivity to the antiandrogen enzalutamide and cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor palbociclib in human prostate cancer cell lines, xenografts, and allografted mouse tumors. Trends were evaluated in TCGA, SU2C, and Beltran 2016 published patient cohorts and a human tissue microarray. Results: Transgenic ERG expression in mice blocked Pten/Trp53 alteration–induced decrease of AR expression and downstream luminal epithelial genes. ERG directly suppressed expression of cell cycle–related genes, which induced RB hypophosphorylation and repressed E2F1-mediated expression of mesenchymal lineage regulators, thereby restricting adenocarcinoma plasticity and maintaining antiandrogen sensitivity. In ERG-negative tumors, CDK4/6 inhibition delayed tumor growth. Conclusions: Our studies identify a previously undefined function of ERG to restrict lineage plasticity and maintain antiandrogen sensitivity in PTEN/TP53–altered prostate cancer. Our findings suggest ERG fusion as a biomarker to guide treatment of PTEN/TP53-altered, RB1-intact prostate cancer. Clin Cancer Res; 24(18); 4551–65. ©2018 AACR.
Open Microvascular Decompression
Pan, James , Kim, Lily H. , Ho, Allen L. , Sussman, Eric S. , Pendharkar, Arjun V. , Burns, Terry C. , Burns, Terry C

Mayo Clinic

Advances in Medical Diagnosis, Treatment, and Care | March 27, 2018 | Volume: No volume available | Issue: No issue available | Pages: 70-103

10.4018/978-1-5225-5349-6.ch004 Get It

Microvascular decompression (MVD) is a neurosurgical procedure used to treat various neuralgias of the cranial nerves. The clinical presentation, natural history, pathophysiology, and medical management of trigeminal neuralgia, hemifacial spasm, glossopharyngeal neuralgia, and nervus intermedius neuralgia is reviewed. A thorough discussion on the retrosigmoid approach for decompression of cranial nerves is presented, along with newer techniques and controversies on adjuvant therapies and neuromonitoring. The surgical outcomes of MVD are discussed, along with alternative techniques to open MVD.
Utility of Pathology Imagebase for standardisation of prostate cancer grading
Egevad, Lars , Delahunt, Brett , Bostwick, David G., Cheville, John C. , Evans, Andrew , Fine, Samson W. , Grignon, David J. , Humphrey, Peter A. , Hörnblad, Jonas, Iczkowski, Kenneth A. , Kench, James G. , Leite, Kátia Ramos Moreira , McKenney, Jesse K. , Pan, Chin‐Chen , Samaratunga, Hemamali , Srigley, John R., Takahashi, Hiroyuki , True, Lawrence D. , Tsuzuki, Toyonori , Varma, Murali , Zhou, Ming , Clements, Mark , McKenney, Jesse K , Pan, Chin-Chen , Tsuzuki, Toyonori , Samaratunga, Hemamali , Berney, Daniel M. , Compérat, Éva , Kristiansen, Glen , Magi‐Galluzzi, Cristina , OXLEY, JON D. , Kwast, Theodorus van der

Mayo Clinic

Histopathology | January 23, 2018 | Volume: 73 | Issue: 1 | Pages: 8-18

10.1111/his.13471 | PMID 29359484 Get It

AimsDespite efforts to standardise grading of prostate cancer, even among experts there is still a considerable variation in grading practices. In this study we describe the use of Pathology Imagebase, a novel reference image library, for setting an international standard in prostate cancer grading.Methods and resultsThe International Society of Urological Pathology (ISUP) recently launched a reference image database supervised by experts. A panel of 24 international experts in prostate pathology reviewed independently microphotographs of 90 cases of prostate needle biopsies with cancer. A linear weighted kappa of 0.67 (95% confidence interval = 0.62–0.72) and consensus was reached in 50 cases. The interobserver weighted kappa varied from 0.48 to 0.89. The highest level of agreement was seen for Gleason score (GS) 3 + 3 = 6 (ISUP grade 1), while higher grades and particularly GS 4 + 3 = 7 (ISUP grade 3) showed considerable disagreement. Once a two‐thirds majority was reached, images were moved automatically into a public database available for all ISUP members at www.isupweb.org. Non‐members are able to access a limited number of cases.ConclusionsIt is anticipated that the database will assist pathologists to calibrate their grading and, hence, decrease interobserver variability. It will also help to identify instances where definitions of grades need to be clarified.
Effects of senescence and angiotensin II on expression and processing of amyloid precursor protein in human cerebral microvascular endothelial cells
Sun, Ruohan , He, Tongrong , Pan, Yujun , Katušić, Zvonimir S.

Mayo Clinic

Aging | January 16, 2018 | Volume: 10 | Issue: 1 | Pages: 100-114

10.18632/aging.101362 | PMID 29348391 Get It

Normative Functional Performance Values in High School Athletes: The Functional Pre-Participation Evaluation Project
Starkel, Cambrie, Clifton, Daniel R. , Best, Thomas M. , Borchers, James, Chaudhari, Ajit M.W. , Comstock, R. Dawn, Cortés, Nelson , Grooms, Dustin R. , Hertel, Jay , Hewett, Timothy E. , Miller, Meghan M., Pan, Xueliang , Schussler, Eric , Lunen, Bonnie L. Van , Oñate, James A.

Mayo Clinic

Journal of Athletic Training | January 9, 2018 | Volume: 53 | Issue: 1 | Pages: 35-42

10.4085/1062-6050-458.16 | PMID 29314871 Get It

Context: The fourth edition of the Preparticipation Physical Evaluation recommends functional testing for the musculoskeletal portion of the examination; however, normative data across sex and grade level are limited. Establishing normative data can provide clinicians reference points with which to compare their patients, potentially aiding in the development of future injury-risk assessments and injury-mitigation programs.Objective: To establish normative functional performance and limb-symmetry data for high school-aged male and female athletes in the United States.Design: Cross-sectional study.Setting: Athletic training facilities and gymnasiums across the United States.Patients or Other Participants: A total of 3951 male and female athletes who participated on high school-sponsored basketball, football, lacrosse, or soccer teams enrolled in this nationwide study.Main Outcome Measure(s): Functional performance testing consisted of 3 evaluations. Ankle-joint range of motion, balance, and lower extremity muscular power and landing control were assessed via the weight-bearing ankle-dorsiflexion–lunge, single-legged anterior-reach, and anterior single-legged hop-for-distance (SLHOP) tests, respectively. We used 2-way analyses of variance and χ2 analyses to examine the effects of sex and grade level on ankle-dorsiflexion–lunge, single-legged anterior-reach, and SLHOP test performance and symmetry.Results: The SLHOP performance differed between sexes (males = 187.8% ± 33.1% of limb length, females = 157.5% ± 27.8% of limb length; t = 30.3, P < .001). A Cohen d value of 0.97 indicated a large effect of sex on SLHOP performance. We observed differences for SLHOP and ankle-dorsiflexion–lunge performance among grade levels, but these differences were not clinically meaningful.Conclusions: We demonstrated differences in normative data for lower extremity functional performance during preparticipation physical evaluations across sex and grade levels. The results of this study will allow clinicians to compare sex- and grade-specific functional performances and implement approaches for preventing musculoskeletal injuries in high school-aged athletes.